ConductScience.org, home

Paper42388231

Biodegradable lipid nanoparticles for genome editing in the brain via intrathecal administration.

Dong S and 14 others. Mater Today (Kidlington), 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Biodegradable lipid nanoparticles for genome editing in the brain via intrathecal administration. Papers, record 42388231. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42388231

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Biodegradable lipid nanoparticles for genome editing in the brain via intrathecal administration.
PubMed
Journal
Mater Today (Kidlington)
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-09-22
PubMed

Authors15

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Dong SSongtao
2Healy LLaurenhttps://orcid.org/0009-0003-5772-3269
3Gong FFanglin
4Xu YYue
5Cai YYunshu
6Solek NCNicholas Chttps://orcid.org/0009-0008-6336-0229
7Chen JJingan
8Zhou MMuye
9Thomson TTylerhttps://orcid.org/0000-0002-1434-1813
10Savguira MMargarita
11Luozhong SSijin
12Zhang YYanchaohttps://orcid.org/0000-0001-7671-725X
13He TTingzhen
14Li GGen
15Li BBowenhttps://orcid.org/0000-0001-5006-9143

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 HL174773NHLBI NIH HHSUnited StatesR01HL174773PubMed

Source NIH RePORTER

Download CSV of grants

References59

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121825241The dynamics of cortical and hippocampal atrophy in Alzheimer disease.Arch Neurol2011https://conductscience.org/library/papers/21825241PubMed
240147373Facile lipid nanoparticle size engineering approach via controllable fusion induced by depletion forces.J Colloid Interface Sci2025https://conductscience.org/library/papers/40147373PubMed
335787388The role of lipid components in lipid nanoparticles for vaccines and gene therapy.Adv Drug Deliv Rev2022https://conductscience.org/library/papers/35787388PubMed
430611663mRNA-Based Protein Replacement Therapy for the Heart.Mol Ther2019https://conductscience.org/library/papers/30611663PubMed
538060560Combinatorial design of ionizable lipid nanoparticles for muscle-selective mRNA delivery with minimized off-target effects.Proc Natl Acad Sci U S A2023https://conductscience.org/library/papers/38060560PubMed
632557988Structural and Functional Thalamic Changes in Parkinson's Disease With Mild Cognitive Impairment.J Magn Reson Imaging2020https://conductscience.org/library/papers/32557988PubMed
731093018Nusinersen: A Novel Antisense Oligonucleotide for the Treatment of Spinal Muscular Atrophy.J Pediatr Pharmacol Ther2019https://conductscience.org/library/papers/31093018PubMed
835064573Translational Approaches for Brain Delivery of Biologics via Cerebrospinal Fluid.Clin Pharmacol Ther2022https://conductscience.org/library/papers/35064573PubMed
939962245Blood-brain-barrier-crossing lipid nanoparticles for mRNA delivery to the central nervous system.Nat Mater2025https://conductscience.org/library/papers/39962245PubMed
1038004577Non-Invasive Drug Delivery across the Blood-Brain Barrier: A Prospective Analysis.Pharmaceutics2023https://conductscience.org/library/papers/38004577PubMed
1127208862Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases.J Control Release2016https://conductscience.org/library/papers/27208862PubMed
1240317512Lipid Nanoparticles Enhance mRNA Delivery to the Central Nervous System Upon Intrathecal Injection.Adv Mater2025https://conductscience.org/library/papers/40317512PubMed
1338898231Gene therapy for CNS disorders: modalities, delivery and translational challenges.Nat Rev Neurosci2024https://conductscience.org/library/papers/38898231PubMed
1428202722Systemic delivery of factor IX messenger RNA for protein replacement therapy.Proc Natl Acad Sci U S A2017https://conductscience.org/library/papers/28202722PubMed
1531467368Fate of nanoparticles in the central nervous system after intrathecal injection in healthy mice.Sci Rep2019https://conductscience.org/library/papers/31467368PubMed
1640653413RNA immunotherapy: revolutionizing cancer and autoimmune disease treatments.Trends Mol Med2026https://conductscience.org/library/papers/40653413PubMed
1727096365Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage.Nature2016https://conductscience.org/library/papers/27096365PubMed
1837304036Advanced genetic therapies for the treatment of Rett syndrome: state of the art and future perspectives.Front Neurosci2023https://conductscience.org/library/papers/37304036PubMed
1939030617Cellular and molecular mechanisms of the blood-brain barrier dysfunction in neurodegenerative diseases.Fluids Barriers CNS2024https://conductscience.org/library/papers/39030617PubMed
2039362024Synthetic nanomaterials for spleen-specific mRNA delivery.Biomaterials2025https://conductscience.org/library/papers/39362024PubMed

See all 59 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

PMIDTitleJournalYearIn PapersSource
42851665Mechanisms and determinants of mRNALipid Nanoparticle biodistribution: From pharmacokinetics to clinical translation.Bioeng Transl Med2026https://conductscience.org/library/papers/42851665PubMed
42198337Delivery of mRNA Therapeutics Beyond Infectious Diseases: Design Innovations and Applications in Oncology, Cardiovascular, and Rare Genetic Diseases.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42198337PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42388231

GET https://conductscience.org/api/papers/v1/42388231/references?page=2